Efficacy and Safety Study of QAW039 in the Treatment of Patients With Moderate to Severe Atopic Dermatitis.
Clinical trial NCT01785602 · COMPLETED
Trial details
- NCT number
- NCT01785602
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2014-11-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.